[ Search ] [ Legislation ] [ Bill Summary ]
[ Home ] [ Back ] [ Bottom ]
90_HB1401
720 ILCS 570/210 from Ch. 56 1/2, par. 1210
Amends the Illinois Controlled Substances Act. Provides
that butorphanol tartrate (Stadol) is a Schedule IV
controlled substance.
LRB9004768RCks
LRB9004768RCks
1 AN ACT to amend the Illinois Controlled Substances Act by
2 changing Section 210.
3 Be it enacted by the People of the State of Illinois,
4 represented in the General Assembly:
5 Section 5. The Illinois Controlled Substances Act is
6 amended by changing Section 210 as follows:
7 (720 ILCS 570/210) (from Ch. 56 1/2, par. 1210)
8 Sec. 210. (a) The controlled substances listed in this
9 Section are included in Schedule IV.
10 (b) Unless specifically excepted or unless listed in
11 another schedule, any material, compound, mixture, or
12 preparation containing limited quantities of any of the
13 following narcotic drugs, or their salts calculated as the
14 free anhydrous base or alkaloid, as set forth below:
15 (1) Not more than 1 milligram of difenoxin (DEA Drug
16 Code No. 9618) and not less than 25 micrograms of atropine
17 sulfate per dosage unit.
18 (2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1,
19 2-diphenyl-3-methyl-2-propionoxybutane).
20 (3) Butorphanol tartrate.
21 (c) Unless specifically excepted or unless listed in
22 another schedule, any material, compound, mixture, or
23 preparation which contains any quantity of the following
24 substances having a potential for abuse associated with a
25 depressant effect on the central nervous system:
26 (1) Alprazolam;
27 (2) Barbital;
28 (2.1) Bromazepam;
29 (2.2) Camazepam;
30 (3) Chloral Betaine;
31 (4) Chloral Hydrate;
-2- LRB9004768RCks
1 (5) Chlordiazepoxide;
2 (5.1) Clobazam;
3 (6) Clonazepam;
4 (7) Clorazepate;
5 (7.1) Clotiazepam;
6 (7.2) Cloxazolam;
7 (7.3) Delorazepam;
8 (8) Diazepam;
9 (8.1) Estazolam;
10 (9) Ethchlorvynol;
11 (10) Ethinamate;
12 (10.1) Ethyl loflazepate;
13 (10.2) Fludiazepam;
14 (10.3) Flunitrazepam;
15 (11) Flurazepam;
16 (12) Halazepam;
17 (12.1) Haloxazolam;
18 (12.2) Ketazolam;
19 (12.3) Loprazolam;
20 (13) Lorazepam;
21 (13.1) Lormetazepam;
22 (14) Mebutamate;
23 (14.1) Medazepam;
24 (15) Meprobamate;
25 (16) Methohexital;
26 (17) Methylphenobarbital (Mephobarbital);
27 (17.1) Midazolam;
28 (17.2) Nimetazepam;
29 (17.3) Nitrazepam;
30 (17.4) Nordiazepam;
31 (18) Oxazepam;
32 (18.1) Oxazolam;
33 (19) Paraldehyde;
34 (20) Petrichloral;
-3- LRB9004768RCks
1 (21) Phenobarbital;
2 (21.1) Pinazepam;
3 (22) Prazepam;
4 (22.1) Quazepam;
5 (23) Temazepam;
6 (23.1) Tetrazepam;
7 (24) Triazolam;
8 (25) Zolpidam.
9 (d) Any material, compound, mixture, or preparation
10 which contains any quantity of the following substances,
11 including its salts, isomers (whether optical, position, or
12 geometric), and salts of such isomers, whenever the existence
13 of such salts, isomers and salts of isomers is possible:
14 (1) Fenfluramine.
15 (e) Unless specifically excepted or unless listed in
16 another schedule any material, compound, mixture, or
17 preparation which contains any quantity of the following
18 substances having a stimulant effect on the central nervous
19 system, including its salts, isomers (whether optical,
20 position or geometric), and salts of such isomers whenever
21 the existence of such salts, isomers, and salts of isomers is
22 possible within the specific chemical designation:
23 (1) Cathine ((+)-norpseudoephedrine);
24 (1.1) Diethylpropion;
25 (1.2) Fencamfamin;
26 (1.3) Fenproporex;
27 (2) Mazindol;
28 (2.1) Mefenorex;
29 (3) Phentermine;
30 (4) Pemoline (including organometallic complexes and
31 chelates thereof);
32 (5) Pipradrol;
33 (6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane).
34 (f) The Department may except by rule any compound,
-4- LRB9004768RCks
1 mixture, or preparation containing any depressant substance
2 listed in subsection (b) from the application of all or any
3 part of this Act if the compound, mixture, or preparation
4 contains one or more active medicinal ingredients not having
5 a depressant effect on the central nervous system, and if the
6 admixtures are included therein in combinations, quantity,
7 proportion, or concentration that vitiate the potential for
8 abuse of the substances which have a depressant effect on the
9 central nervous system.
10 (g) Any material, compound, mixture, or preparation that
11 contains any quantity of the following substance having a
12 stimulant effect on the central nervous system, including its
13 salts, enantiomers (optical isomers) and salts of enantiomers
14 (optical isomers):
15 (1) Ephedrine as the only active medicinal
16 ingredient or in combination with therapeutically
17 insignificant quantities of another active medicinal
18 ingredient.
19 (Source: P.A. 89-202, eff. 10-1-95.)